Assenagon Asset Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.2M | Buy |
|
|||||
|
2025
Q2 | $144K | Sell |
|
|||||
|
2025
Q1 | $175K | Buy |
|
|||||
|
2024
Q4 | $65.5K | Sell |
|
|||||
|
2024
Q3 | $102K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $349K | Buy |
|
|||||
|
2023
Q4 | $253K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $57K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.12M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $3.76M | Buy |
|
|||||
|
2020
Q1 | $358K | Buy |
|
|||||
|
2019
Q4 | $274K | Buy |
|